Fibrin-targeted thrombolytic therapy using acoustically reflective perfluorocarbon nanoparticles

J. N. Marsh, A. Pan, G. Hu, K. C. Crowder, M. J. Scott, M. S. Hughes, S. A. Wickline, G. M. Lanza

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Scopus citations

Abstract

Thrombolytic agents, i.e. "clot-busters" such as tPA, have been shown to be effective therapeutics for acute ischemic stroke. However, systemic administration of such powerful agents may be complicated by increased risk of cerebral hemorrhage and expanding stroke. Targeting of clot-dissolving therapeutics has the potential to decrease the incidence of these complications while simultaneously increasing effectiveness of treatment, by concentrating the available drug at the desired site and permitting a lower overall systemic dose. We have previously demonstrated targeting of liquid perfluorocarbon nanoparticles to thrombi in vitro and in vivo, with concomitant enhancement of acoustic reflectivity from the targeted clot surfaces. In the current study, a traditional thrombolytic enzyme (streptokinase) was incorporated into fibrin-targeted nanoparticles and targeted to plasma clots in vitro to demonstrate use of the nanoparticles as both an acoustic contrast agent and an adjunctive targeted therapeutic delivery system. Human plasma clot samples targeted with streptokinase-loaded liquid perfluorocarbon nanoparticles and immersed in plasminogen/saline solution exhibited 7% loss of volume after 3 hrs exposure, as well as marked time-dependent variation in surface topography and acoustic reflectivity. Control samples exposed to either 1) targeted, streptokinase-loaded nanoparticles in the presence of saline only, or 2) targeted nanoparticles without streptokinase in the presence of plasminogen/saline solution exhibited no significant changes over time. These results suggest the potential utility of targeted nanoparticles for combined diagnosis and treatment of thrombus-initiated ischemic stroke.

Original languageEnglish
Title of host publication2005 IEEE Ultrasonics Symposium
Pages992-995
Number of pages4
DOIs
StatePublished - Dec 1 2005
Event2005 IEEE Ultrasonics Symposium - Rotterdam, Netherlands
Duration: Sep 18 2005Sep 21 2005

Publication series

NameProceedings - IEEE Ultrasonics Symposium
Volume2
ISSN (Print)1051-0117

Conference

Conference2005 IEEE Ultrasonics Symposium
CountryNetherlands
CityRotterdam
Period09/18/0509/21/05

Keywords

  • Contrast
  • Nanoparticle
  • Perfluorocarbon
  • Stroke
  • Targeting
  • Thrombolysis

Fingerprint Dive into the research topics of 'Fibrin-targeted thrombolytic therapy using acoustically reflective perfluorocarbon nanoparticles'. Together they form a unique fingerprint.

  • Cite this

    Marsh, J. N., Pan, A., Hu, G., Crowder, K. C., Scott, M. J., Hughes, M. S., Wickline, S. A., & Lanza, G. M. (2005). Fibrin-targeted thrombolytic therapy using acoustically reflective perfluorocarbon nanoparticles. In 2005 IEEE Ultrasonics Symposium (pp. 992-995). [1603017] (Proceedings - IEEE Ultrasonics Symposium; Vol. 2). https://doi.org/10.1109/ULTSYM.2005.1603017